No abstract available
Publication types
-
Clinical Trial, Phase II
-
Letter
-
Multicenter Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Antibodies, Monoclonal, Murine-Derived / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Blood Proteins / analysis
-
Blood Proteins / immunology
-
Cyclophosphamide / therapeutic use
-
Cytarabine / administration & dosage
-
Doxorubicin / therapeutic use
-
Etoposide / therapeutic use
-
Female
-
Humans
-
Immunophenotyping / methods*
-
Lymphoma, Follicular / blood
-
Lymphoma, Follicular / diagnosis
-
Lymphoma, Follicular / drug therapy
-
Lymphoma, Follicular / immunology
-
Lymphoma, Large B-Cell, Diffuse / blood*
-
Lymphoma, Large B-Cell, Diffuse / diagnosis
-
Lymphoma, Large B-Cell, Diffuse / drug therapy
-
Lymphoma, Large B-Cell, Diffuse / mortality
-
Male
-
Methotrexate / administration & dosage
-
Middle Aged
-
Monitoring, Physiologic / methods
-
Prednisolone / therapeutic use
-
Prednisone / therapeutic use
-
Prognosis
-
Protein Array Analysis / methods*
-
Proteomics / methods
-
Risk Factors
-
Rituximab
-
Survival Analysis
-
Vincristine / therapeutic use
-
Young Adult
Substances
-
Antibodies, Monoclonal, Murine-Derived
-
Blood Proteins
-
R-CHOP protocol
-
Cytarabine
-
Rituximab
-
Vincristine
-
Etoposide
-
Doxorubicin
-
Cyclophosphamide
-
Prednisolone
-
Prednisone
-
Methotrexate